Stop AI Hallucinations From Destroying Your Drug Brand Value
AI is moving from “nice-to-have” to “boardroom-critical” in pharma—but one failure mode is quietly becoming a brand risk: hallucinations.
If your teams are using AI to draft claims, summarize clinical evidence, generate competitive intelligence, or spe…
Stop AI Hallucinations From Destroying Your Drug Brand Value Read Post »
